Skip to main content

Table 3 Association between CLU expression and clinicopathological factors in early-stage ovarian cancer

From: Clusterin is a potential molecular predictor for ovarian cancer patient's survival: targeting Clusterin improves response to paclitaxel

Factor CLU expression P-value
  Low high  
Age    0.83
<50 16 8  
> = 50 16 7  
Histology    0.32
Serous/endometrioid 11 3  
Mucinous/clear cell 21 12  
Stage    0.09
Ia/b 13 2  
Ic/II 19 13